Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma
Clinical trial NCT05561374 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05561374
- Sponsor
- Oblato, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-17
- Primary completion
- 2025-05-31
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.